Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr-Jun;5(2):17-42.

HISTOPATHOLOGIC PATTERN OF BLADDER CANCERS IN IBADAN SOUTHWEST NIGERIA: AN UPDATE

A O Takure  1 , M O Odubanjo  2 , S A Adebayo  1 , O Oluwasola  2 , O B Shittu  1 , L I Okeke  1 , O A Fadimu  3 , E O Olapade-Olaopa  1
Affiliations

HISTOPATHOLOGIC PATTERN OF BLADDER CANCERS IN IBADAN SOUTHWEST NIGERIA: AN UPDATE

A O Takure et al. J West Afr Coll Surg. 2015 Apr-Jun.

Abstract

Background: A study from the University College Hospital, Ibadan, Southwest, Nigeria on bladder cancers had described an increase in the frequency of urothelial carcinoma compared to the earlier reported preponderance of squamous-cell carcinoma.

Aim: To provide an update on the histopathologic pattern of bladder cancers in our community and to explore its implications for future health system policies.

Methods: The records of the Ibadan Cancer Registry from January 1997 to December 2014 were reviewed and the data analyzed for the histologic subtypes of bladder cancers diagnosed in the hospital.

Results: Two hundred and sixteen bladder tumours were recorded during this period with a male to female ratio of 3.2:1. Complete information was available in 195 cases of which 181 (96.8%) were bladder carcinomas whilst 14 were sarcomas. Of the bladder carcinomas, 68.5%, 19.9% and 11.6% were urothelial carcinomas, squamous cell carcinomas, and adenocarcinomas (AC) respectively. Urothelial carcinoma was more common in all age groups and its peak age of occurrence was in the 51-60 year age group. The peak age for squamous cell carcinoma was in the 41-50 year age group. Mean and median age of occurrence was significantly lower in females in the urothelial and squamous cell carcinomas, but lowest in squamous cell carcinoma [P = < 0.0001].

Conclusion: This population study has confirmed urothelial carcinoma as the predominant histotype of bladder cancer in Ibadan, Southwest Nigeria currently and that both urothelial and squamous cell carcinomas occur earlier in women.

Keywords: Bladder carcinoma; Epidemiology; Ibadan; Nigeria; Schistosomiasis; Squamous cell carcinoma; Urothelial carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Prevalence of Schistosomiasis and Predominant Bladder Histotypes and the distribution of Tobacco and Petrochemical Industries in Nigeria
See this image and copyright information in PMC

References

    1. World Health Organization Geneva. Chapter II, Tumours of the Urinary System. In: Eble JN, Sauter G, Epstein JI, and Sesterhenn IA, editors. World Health Organization Classification of Tumours,Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: International Agency for Research on Cancer (IARC) Press; 2004.
    1. Rambau PF, Chalya PL, Jackson K. Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients. Infect Agent Cancer. 2013;8(1):19–24. - PMC - PubMed
    1. Chung KT. The Etiology of Bladder Cancer and its Prevention. J Cancer Sci Ther. 2013;5:343–361.
    1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. IARC Scientific Publications. Vol. 155. Lyon: IARC Press; 2003. Cancer Incidence in Five Continents.
    1. Zheng Y-L, Amr S, Saleh DA, Dash C, Ezzat S, Mikhail NN, Loffredo CA. Urinary bladder cancer risk factors in Egypt: a multi-center case-control study. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2012;21(3):537–546. - PMC - PubMed

LinkOut - more resources